Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 14 de 14
Filtrar
1.
Colorectal Dis ; 14(6): 721-6, 2012 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-21834877

RESUMO

AIM: Brain metastases from colorectal cancer are rare, with an incidence of 0.6-4%. The risk and outcome of brain metastases after hepatic and pulmonary metastasectomy have not been previously described. This study aimed to determine the incidence, predictive factors, treatment and survival of patients developing colorectal brain metastases, who had previously undergone resection of hepatic metastases. METHOD: A retrospective review was carried out of a prospectively maintained database of patients undergoing liver resection for colorectal metastases. RESULTS: Fifty-two (4.0%) of 1304 patients were diagnosed with brain metastases. The annual incidence rate was 1.03% per person-year. In the majority of cases brain metastases were found as part of multifocal disease. Median survival was 3.2 months (95% CI: 2.3-4.1), but was best for six patients treated with potentially curative resection [median survival = 13.2 (range, 4.9-32.1) months]. Multivariate analysis showed that a lymph node-positive primary tumour [hazard ratio (HR) = 2.7, 95% CI: 1.8-6.19; P = 0.019], large liver metastases (> 6 cm) [HR = 2.23, 95% CI: 1.19-2.33; P = 0.012] and recurrent intrahepatic and extrahepatic disease [HR = 2.11, 95% CI: 1.2-4.62; P = 0.013] were independent predictors for the development of brain metastases. CONCLUSION: The annual risk of developing brain metastases following liver resection for colorectal metastases is low, but highest for patients presenting with a Dukes' C primary tumour, large liver metastases or who subsequently develop disseminated disease. The overall survival from colorectal brain metastases is poor, but resection with curative intent offers patients their best chance of medium-term survival.


Assuntos
Neoplasias Encefálicas/epidemiologia , Neoplasias Encefálicas/secundário , Neoplasias Colorretais/patologia , Neoplasias Hepáticas/secundário , Neoplasias Hepáticas/cirurgia , Neoplasias das Glândulas Suprarrenais/secundário , Adulto , Idoso , Idoso de 80 Anos ou mais , Neoplasias Ósseas/secundário , Neoplasias Encefálicas/terapia , Carcinoma/secundário , Carcinoma/terapia , Feminino , Humanos , Incidência , Estimativa de Kaplan-Meier , Neoplasias Hepáticas/patologia , Neoplasias Pulmonares/secundário , Metástase Linfática , Masculino , Pessoa de Meia-Idade , Análise Multivariada , Modelos de Riscos Proporcionais , Estudos Retrospectivos , Fatores de Risco
2.
Science ; 256(5055): 379-82, 1992 Apr 17.
Artigo em Inglês | MEDLINE | ID: mdl-1566086

RESUMO

3T3-L1 adipoblasts that express large amounts of c-Myc cannot terminally differentiate, raising the possibility that Myc inhibits the expression of genes that promote adipogenesis. The CCAAT/enhancer binding protein (C/EBP alpha) is induced during 3T3-L1 adipogenesis when cells commit to the differentiation pathway. Transfection of 3T3-L1 adipoblasts with the gene that encodes C/EBP alpha caused overt expression of the adipocyte morphology. Expression of Myc prohibited the normal induction of C/EBP alpha and prevented adipogenesis. Enforced expression of C/EBP alpha overcame the Myc-induced block to differentiation. These results provide a molecular basis for the regulation of adipogenesis and implicate Myc and C/EBP alpha as pivotal controlling elements.


Assuntos
Tecido Adiposo/citologia , Proteínas de Ligação a DNA/fisiologia , Regulação da Expressão Gênica , Proteínas Nucleares/fisiologia , Proteínas Proto-Oncogênicas c-myc/fisiologia , Tecido Adiposo/metabolismo , Animais , Sequência de Bases , Proteínas Estimuladoras de Ligação a CCAAT , Diferenciação Celular , Divisão Celular , Linhagem Celular , Proteínas de Ligação a DNA/genética , Dados de Sequência Molecular , Proteínas Nucleares/genética , Plasmídeos , Reação em Cadeia da Polimerase , Proteínas Proto-Oncogênicas c-myc/genética , RNA Mensageiro/análise , Ratos , Transfecção
3.
Br J Pharmacol ; 154(3): 663-74, 2008 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-18414394

RESUMO

BACKGROUND AND PURPOSE: 5-HT is a vasoconstrictor exhibiting enhanced effects in systemic arteries from subjects with cardiovascular disease. The effect of endogenous 5-HT on arteries is controversial, because the concentration of free circulating 5-HT is low and a 5-hydroxytryptaminergic system has not been identified in peripheral arteries. We hypothesized that a local 5-hydroxytryptaminergic system (including 5-HT synthesis, metabolism, uptake and release) with physiological function exists in peripheral arteries. EXPERIMENTAL APPROACH: The presence of key components of a 5-hydroxytryptaminergic system in rat aorta and superior mesenteric artery was examined using western blot analyses, immunohistochemistry and immunocytochemistry. The function of the rate-limiting enzyme in 5-HT biosynthesis, tryptophan hydroxylase (TPH), and 5-HT transporter was tested by measuring enzyme activity and 5-HT uptake, respectively. Isometric contraction of arterial strips was used to demonstrate the function of released endogenous 5-HT in arterial tissues. KEY RESULTS: mRNA for TPH-1 was present in arteries, with low levels of TPH protein and TPH activity. Expression and function of MAO A (5-HT metabolizing enzyme) was supported by immunohistochemistry, western analyses and the elevation of concentrations of 5-hydroxyindoleacetic acid (5-HT metabolite) after exposure to exogenous 5-HT. The 5-HT transporter was localized to the plasma membrane of freshly isolated aortic smooth muscle cells. Peripheral arteries actively took up 5-HT in a time-dependent and 5-HT transporter-dependent manner. The 5-HT transporter substrate, (+)-fenfluramine, released endogenous 5-HT from peripheral arteries, which potentiated noradrenaline-induced arterial contraction. CONCLUSIONS AND IMPLICATIONS: This study revealed the existence of a local 5-hydroxytryptaminergic system in peripheral arteries.


Assuntos
Aorta Torácica/metabolismo , Artéria Mesentérica Superior/metabolismo , Serotonina/metabolismo , Animais , Western Blotting , Expressão Gênica , Imuno-Histoquímica , Contração Isométrica , Masculino , Monoaminoxidase/metabolismo , RNA Mensageiro/metabolismo , Ratos , Ratos Sprague-Dawley , Proteínas da Membrana Plasmática de Transporte de Serotonina/metabolismo , Fatores de Tempo , Triptofano Hidroxilase/metabolismo
4.
Mol Cell Biol ; 11(4): 2291-5, 1991 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-2005911

RESUMO

High levels of c-Myc in mouse 3T3-L1 cells specifically suppress the expression of three collagen genes. This effect is exerted through collagen promoter sequences and requires the leucine zipper motif of c-Myc. Our data suggest that an important aspect of c-Myc transforming activity is the ability to suppress specific cellular gene transcription.


Assuntos
Colágeno/genética , Expressão Gênica , Genes myc , Supressão Genética , Transcrição Gênica , Animais , Linhagem Celular , Zíper de Leucina , Camundongos , Regiões Promotoras Genéticas
5.
Cancer Res ; 58(18): 4047-51, 1998 Sep 15.
Artigo em Inglês | MEDLINE | ID: mdl-9751607

RESUMO

Previously, we found a positive correlation between the expression of platelet-type 12-lipoxygenase (12-LOX) and the progression of human prostate adenocarcinoma (PCa; Gao et al., Urology, 46: 227-237, 1995). To determine the role of 12-LOX in PCa progression, we generated stable 12-LOX-transfected PC3 cells, which synthesize high levels of 12-LOX protein and 12(S)-hydroxyeicosatetraenoic acid metabolite. In vitro, 12-LOX-transfected PC3 cells demonstrated a proliferation rate similar to neo controls. However, following s.c. injection into athymic nude mice, 12-LOX-transfected PC3 cells formed larger tumors than did the controls. Decreased necrosis and increased vascularization were observed in the tumors from 12-LOX-transfected PC3 cells. Both endothelial cell migration and Matrigel implantation assays indicate that 12-LOX-transfected PC3 cells were more angiogenic than their neo controls. These data indicate that 12-LOX stimulates human PCa tumor growth by a novel angiogenic mechanism.


Assuntos
Araquidonato 12-Lipoxigenase/fisiologia , Proteínas de Neoplasias/fisiologia , Neovascularização Patológica/patologia , Neoplasias da Próstata/irrigação sanguínea , Ácido 12-Hidroxi-5,8,10,14-Eicosatetraenoico/fisiologia , Animais , Araquidonato 12-Lipoxigenase/genética , Divisão Celular , Humanos , Masculino , Camundongos , Camundongos Endogâmicos BALB C , Camundongos Nus , Proteínas de Neoplasias/genética , Neovascularização Patológica/enzimologia , Neoplasias da Próstata/enzimologia , Neoplasias da Próstata/patologia , Ratos , Transfecção
6.
Gene ; 158(2): 231-5, 1995 Jun 09.
Artigo em Inglês | MEDLINE | ID: mdl-7607547

RESUMO

The recognition sequence (CIB) of collagen intron-binding factor I (CIBF-I) loosely resembles the consensus octamer-binding motif (OCT). In the present study we investigate whether CIBF-I is actually the OCT-binding protein, Oct-1. Electrophoretic mobility-shift assays (EMSA) demonstrate that a consensus OCT motif effectively competes for CIBF-I binding. CIBF-I and Oct-1 complexes display similar EMSA characteristics, and both factors are detected in nuclear extracts of five different cell types. In addition, pre-incubation of nuclear extracts with antiserum directed against the POU domain of Oct-1 inhibits CIBF-I complex formation. Finally, DNA transfection experiments demonstrate that a single copy of the CIB site is sufficient to stimulate transcription from the SV40 early promoter in NIH 3T3 cells. These results suggest that CIBF-I is the ubiquitously distributed OCT-binding protein, Oct-1, and represent the first report that an octamer-binding protein contributes to the transcriptional activity of a collagen-encoding gene.


Assuntos
Colágeno/genética , Proteínas de Ligação a DNA/genética , Fatores de Transcrição/genética , Transcrição Gênica , Animais , Sequência de Bases , Sítios de Ligação/genética , Ligação Competitiva , Colágeno/biossíntese , Sequência Consenso , Reações Cruzadas , Proteínas de Ligação a DNA/imunologia , Proteínas de Ligação a DNA/metabolismo , Regulação da Expressão Gênica , Fator C1 de Célula Hospedeira , Camundongos , Dados de Sequência Molecular , Fator 1 de Transcrição de Octâmero , Ligação Proteica , Fatores de Transcrição/imunologia , Fatores de Transcrição/metabolismo
7.
Ann N Y Acad Sci ; 914: 92-103, 2000 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-11085312

RESUMO

Methamphetamine (METH) and 3,4-methylenedioxymethamphetamine (MDMA or Ecstasy) are amphetamine analogs with high abuse potential. These drugs also cause damage to dopamine and serotonin nerve terminals in vivo. The mechanisms by which these drugs cause neurotoxicity are not known, but a great deal of attention has been focused on reactive oxygen species (ROS) and reactive nitrogen species (RNS) as mediators of this toxicity. ROS and RNS have very short biological half-lives in vivo, and it is virtually impossible to measure them in brain directly. However, ROS and RNS are also characterized by their extreme reactivity with proteins and nucleotides. Tryptophan hydroxylase (TPH) and tyrosine hydroxylase (TH), the initial and rate limiting enzymes in the synthesis of serotonin and dopamine, respectively, are identified targets for the actions of METH and MDMA. Using recombinant forms of these proteins, we have found that nitric oxide, catechol-quinones, and peroxynitrite, all of which are potentially produced by the neurotoxic amphetamines, covalently modify both TPH and TH. The ROS and RNS cause reductions in catalytic function of these enzymes in a manner that is consistent with the effects of METH and MDMNA in vivo. Protein-bound ROS or RNS may serve as molecular footprints of neurotoxic amphetamine action.


Assuntos
Anfetaminas/toxicidade , Neurotoxinas/toxicidade , Pegadas de Proteínas/métodos , Western Blotting/métodos , Relação Dose-Resposta a Droga , Interações Medicamentosas , Concentração de Íons de Hidrogênio , Técnicas In Vitro , Peso Molecular , Ácido Peroxinitroso/farmacologia , Tetranitrometano/metabolismo , Tirosina 3-Mono-Oxigenase/metabolismo
8.
Forensic Sci Int ; 208(1-3): 149-55, 2011 May 20.
Artigo em Inglês | MEDLINE | ID: mdl-21216545

RESUMO

During the last decade or so there has been some discussion in the forensic community in the United Kingdom concerning whether it is necessary to search the pockets for glass particles in garments attributed to suspects arrested for glass breaking crimes. The removal of this practice would help expedite the searching and recovery process since examining only the surfaces of clothing would reduce the cost of recovering glass evidence. However, it is believed by many scientists that some glass fragments originally acquired in pockets can migrate to the surfaces of clothing prior to examination by the forensic scientist. As glass fragments have been encountered in the pockets of garments during examinations of casework items in the LGC Laboratories, the implications of this change in practice needs to be assessed. Hence, the aim of this study was to investigate this possibility that fragments of glass migrate from a pocket of a garment to its surfaces during police and laboratory handling after a person is suspected of breaking glass during an offence. If this occurs to a significant extent then it could affect the evaluation of the glass evidence when using a Bayesian approach. Sixty fragments of glass were seeded into a pocket of a fleece jacket and a pair of denim jeans. Three experiments were performed; one examined a searching, recovery and blanking procedure, another examined the pre-laboratory 'handling' process of an item in an evidence bag, and the third experiment looked at the removal of an object from a pocket laden with glass and subsequent removal and packaging of the garment. Up to two (3.3%) fragments were recovered from the surfaces of the fleece jacket and the denim jeans via the searching, recovery and blanking procedure. Similar numbers were also recovered from the insides of the evidence bags. Up to four (6.7%) fragments were recovered from the surface of the fleece jacket and up to five (8.3%) fragments were recovered from the surface of the denim jeans after pre-laboratory 'handling'. Again similar numbers were recovered from the insides of the evidence bags. Comparable numbers to those from searching/recovery experiments were observed when garments were removed after taking an object from a pocket. In addition, up to two (3.3%) fragments were recovered from the object (a mobile phone). The findings show that some migration can occur particularly in the second experiment and therefore modification of the evaluation strategy may be required.

10.
J Biol Chem ; 274(42): 29726-32, 1999 Oct 15.
Artigo em Inglês | MEDLINE | ID: mdl-10514446

RESUMO

Tryptophan hydroxylase, the initial and rate-limiting enzyme in serotonin biosynthesis, is inactivated by peroxynitrite in a concentration-dependent manner. This effect is prevented by molecules that react directly with peroxynitrite such as dithiothreitol, cysteine, glutathione, methionine, tryptophan, and uric acid but not by scavengers of superoxide (superoxide dismutase), hydroxyl radical (Me(2)SO, mannitol), and hydrogen peroxide (catalase). Assuming simple competition kinetics between peroxynitrite scavengers and the enzyme, a second-order rate constant of 3.4 x 10(4) M(-1) s(-1) at 25 degrees C and pH 7.4 was estimated. The peroxynitrite-induced loss of enzyme activity was accompanied by a concentration-dependent oxidation of protein sulfhydryl groups. Peroxynitrite-modified tryptophan hydroxylase was resistant to reduction by arsenite, borohydride, and dithiothreitol, suggesting that sulfhydryls were oxidized beyond sulfenic acid. Peroxynitrite also caused the nitration of tyrosyl residues in tryptophan hydroxylase, with a maximal modification of 3.8 tyrosines/monomer. Sodium bicarbonate protected tryptophan hydroxylase from peroxynitrite-induced inactivation and lessened the extent of sulfhydryl oxidation while causing a 2-fold increase in tyrosine nitration. Tetranitromethane, which oxidizes sulfhydryls at pH 6 or 8, but which nitrates tyrosyl residues at pH 8 only, inhibited tryptophan hydroxylase equally at either pH. Acetylation of tyrosyl residues with N-acetylimidazole did not alter tryptophan hydroxylase activity. These data suggest that peroxynitrite inactivates tryptophan hydroxylase via sulfhydryl oxidation. Modification of tyrosyl residues by peroxynitrite plays a relatively minor role in the inhibition of tryptophan hydroxylase catalytic activity.


Assuntos
Nitratos/farmacologia , Compostos de Sulfidrila/química , Triptofano Hidroxilase/farmacologia , Catálise , Cinética , Nitratos/metabolismo , Tetranitrometano/farmacologia , Triptofano Hidroxilase/química
11.
J Neurosci ; 19(23): 10289-94, 1999 Dec 01.
Artigo em Inglês | MEDLINE | ID: mdl-10575026

RESUMO

Tyrosine hydroxylase (TH) is the initial and rate-limiting enzyme in the biosynthesis of dopamine (DA). TH activity is significantly diminished in Parkinson's disease (PD) and by the neurotoxic amphetamines, thereby accentuating the reductions in DA associated with these conditions. Reactive oxygen and nitrogen species have been implicated in the damage to DA neurons seen in PD and in reaction to amphetamine drugs of abuse, so we investigated the hypothesis that peroxynitrite (ONOO(-)) could interfere with TH catalytic function. ONOO(-) caused a concentration-dependent inactivation of TH. The inactivation was associated with tyrosine nitration (maximum of four tyrosine residues nitrated per TH monomer) and extensive sulfhydryl oxidation. Tetranitromethane, which causes sulfhydryl oxidation at pH 6 and 8 but which nitrates tyrosines only at pH 8, inactivated TH equally at either pH. Bicarbonate protected TH from ONOO(-)-induced inactivation and sulfhydryl oxidation but increased significantly tyrosine nitration. PNU-101033 blocked ONOO(-)-induced tyrosine nitration in TH but could not prevent enzyme inactivation or sulfhydryl oxidation. Together, these results indicate that the inactivation of TH by ONOO(-) is mediated by sulfhydryl oxidation. The coincident nitration of tyrosine residues appears to exert little influence over TH catalytic function.


Assuntos
Nitratos/farmacologia , Oxidantes/farmacologia , Compostos de Sulfidrila/metabolismo , Tirosina 3-Mono-Oxigenase/metabolismo , Bicarbonatos/farmacologia , Ativação Enzimática/efeitos dos fármacos , Nitratos/metabolismo , Oxirredução , Pirimidinas/farmacologia , Pirróis/farmacologia , Tetranitrometano/farmacologia , Tirosina/metabolismo , Tirosina 3-Mono-Oxigenase/antagonistas & inibidores , Tirosina 3-Mono-Oxigenase/efeitos dos fármacos
14.
Br Med J ; 2(5805): 114, 1972 Apr 08.
Artigo em Inglês | MEDLINE | ID: mdl-5018297
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA